Clinical Trial Update: Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on convalescent plasma for treatment of critically ill Covid-19 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-associated Coronavirus Infection

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Hospital de Infecciosas Francisco Javier Muniz | Conditions: SARS-Associated Coronavirus, Covid19 | Phase 2 | Status: COMPLETED